Who Advises Hospitals and Health Plans? One Firm, Several Bands Clear

General counsel at hospital systems and health plans who compare healthcare law firms will find a market with one clear front-runner. Sartori & Partners data show 1,110 deals for healthcare provider and payor clients in the 12 months to October 2026, or 2.3% of all dated deals. Bass, Berry & Sims advised on 101-150 of them. The next firm, Wheeler Trigg O'Donnell, sits in the 21-40 band, several bands lower. Nashville, not a coastal financial center, ranks fourth among the cities where the sector's deal work is done. Disputes, not financings, are the largest type of work and health care specialists are credited far above the market rate. Each of those facts changes how a company should pick, price and back up its outside counsel.

Firms are shown as bands of deals advised, not exact counts. Bass, Berry & Sims stands alone in the 101-150 band. The five firms ranked second to sixth, from Wheeler Trigg O'Donnell to Ropes & Gray, all share the 21-40 band, and the last four of the top 10 sit in the 11-20 band. Most of the names below first place are national platforms that also work across pharma, finance and private equity. The front-runner is a Nashville firm whose sector volume puts it in a class of its own.

Neighboring sectors are shaped differently. In pharma and biotech, Cooley and Goodwin Procter share the 251-400 band, so a pharma company has two firms of equal volume to play against each other. In medical devices the first three firms, led by Latham & Watkins, all sit in the 21-40 band. In insurance, Skadden, Arps, Slate, Meagher & Flom LLP & Affiliates leads from the 41-60 band, one step above the 21-40 of the firm in second. Of these four sectors, only hospitals and health plans have a single adviser this far clear of the rest.

Concentration cuts two ways for a buyer. The busiest firm has seen more of the sector's deals and disputes than anyone else, which shortens the learning curve on a mandate. It also acts for many of a company's competitors, counterparties and acquirers, so conflicts will rule it out of some matters. A hospital system or plan should know before a deal starts which of the five firms in the 21-40 band it would call when the first choice is conflicted.

Lawyers in Nashville worked on 12.4% of the sector's deals. That places Nashville fourth, behind New York at 27.3%, Washington at 18.0% and Chicago at 14.7%, and ahead of San Francisco at 10.0% and Boston at 9.3%. Memphis also makes the list at 4.1%. The figures show where the work is done, not how many lawyers sit in each city: one deal can count in several cities, so the shares add to more than the whole.

The neighboring sectors keep their deal work in the large financial centers. In pharma and biotech, lawyers in Boston worked on 25.5% of deals and lawyers in New York on 45.9%. In insurance, lawyers in London worked on 22.9% of deals. Nashville does not reach the top 10 cities of pharma and biotech, medical devices or insurance. Nashville has long been home to hospital operators and the advisers around them, and the deal record reflects it. For a company, that means real sector depth at Nashville billing rates, and partners who can staff a hospital transaction or a payor dispute without flying in a New York team.

Disputes and investigations make up 39.2% of the sector's deals, 14.2 points above the market's 25.0%. Capital markets, the largest type across all sectors at 25.7%, falls to 11.8% here, and M&A sits at 23.4% against 19.3%. In the Sartori & Partners deal record the sector logged 435 disputes against 260 M&A deals. Some deals carry no type, so these shares should be read against one another, not as a full split of the work.

Pharma and biotech runs the other way, with capital markets at 52.4% of its deals and disputes at 9.6%. A hospital system or plan therefore spends most of its outside counsel budget defending claims and answering regulators, not raising money. The relationship partner who matters most is the litigator, and that is where fee arrangements deserve the closest work.

Sartori & Partners data show health care lawyers on 16.7% of the sector's deals, against 0.5% of all deals, far above the market rate. Product liability and torts lawyers appear on 11.0%, against 2.1% market-wide. Corporate and M&A lawyers remain the most frequent practice at 29.6%, above the market's 23.3%. A deal can involve several practices, so these shares overlap.

Reimbursement, licensing, fraud and abuse rules and payor contracts sit inside almost every transaction and dispute in this sector. A general corporate team without a health care regulatory partner on the matter will either bring one in at extra cost or miss something. Ask each firm on a pitch which named health care lawyer will work the matter, and how many hours that partner is expected to bill.

Hospital and health plan deal flow rose 13.4% year on year, 1,084 against 956 in the settled 12-month windows. Over the same windows the whole deal market rose 10.6%, from 43,590 to 48,216. Pharma and biotech rose 14.5%. Medical device deal flow held flat (+6.9%), and insurance deal flow held flat (+1.3%).

The lateral market did not add to the specialist pool. The number of lawyers with a provider and payor focus who changed firms held flat (+0.0%), 344 against 344. Lateral hiring brought no extra specialists into a sector with more work, so a company should not count on new arrivals to ease staffing.

Name the second firm now. With Bass, Berry & Sims in the 101-150 band and no other adviser above 21-40, the most active firm will often be conflicted on the matters that matter most: a competitor's acquisition, a payor dispute with a system it represents. Pick a backup from the five firms that share the second band, give it real work during the year, and it will know the business when the conflict arrives.

Use Nashville on price. Lawyers in Nashville worked on 12.4% of the sector's deals, so sector depth is not confined to New York or Washington rates. Ask coastal firms to price against that alternative, and staff repeat regulatory and dispute matters from lower-cost offices.

Budget for disputes and lock in specialists. Disputes run at 39.2% of the sector's deals, and deal flow rose 13.4% while the count of lateral moves by lawyers with this focus was flat at 344 against 344. Negotiate rates and named staffing for the year ahead before rising demand makes health care partners harder to secure.